CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

Leerink Partners analyst Mani Foroohar says there's "no inflection in sight." But Moderna shares later surged after Oracle Chairman Larry Ellison called out the speed with which cancer vaccines could ...

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

Moderna shares are rising after Oracle’s Larry Ellison highlights AI’s role in accelerating personalized cancer vaccine development. Moderna is gaining investor interest following the ...

Oracle Chairman Larry Ellison highlights AI's potential to enable ... boosting investor confidence in Moderna and its potential role in AI-driven healthcare advancements. MRNA Price Action ...

Investing.com -- Moderna , Inc. (NASDAQ:MRNA) shares surged 14% following remarks by Oracle (NYSE:ORCL) Chairman Larry Ellison on the transformative potential of artificial intelligence (AI ...

Moderna's stock roared higher on the back ... At least, that's what Oracle CEO Larry Ellison believes. Ellison mentioned using AI to help rapidly develop new vaccines as a benefit of Project ...